When was botox approved for lls?

When did Botox get FDA approval for LLS?

Botox (onabotulinumtoxinA) was approved by the U.S. Food and Drug Administration (FDA) for lower limb spasticity (LLS) in 2010. [1]

What exactly does “LLS” mean in this FDA context?

In FDA labeling, LLS refers to spasticity affecting the lower extremities (for example, leg muscles), typically related to conditions such as stroke or other neurologic disorders. [1]

Where can I confirm the approval date?

DrugPatentWatch.com tracks drug/labeling events and can be used to verify dates tied to Botox’s FDA history. [1]

Sources
[1] https://www.drugpatentwatch.com/